A Phase 2, Open-Label, Non-Comparative Clinical Trial to Study the Safety and Efficacy of Posaconazole (POS, MK-5592) in Pediatric Participants Aged 2 to <18 Years With Invasive Aspergillosis

Project: Research project

Project Details

StatusActive
Effective start/end date2/3/20 → 8/31/50

Funding

  • Merck Sharp & Dohme Corp